Intelligent Retinal Imaging Systems (IRIS) has announced it has successfully closed a round of Series B financing.

IRIS, based in Pensacola, Fla., is a developer of early detection systems for diabetic eye disease.

The financing round was led by Ballast Point Ventures, a later-stage venture capital and growth equity firm based in Tampa, Fla. Ballast Point invests in privately owned companies in the healthcare and technology industries.

IRIS indicated that the funds raised will be used to support the company’s expansion and growth strategy.